Thalidomide Combined With Azathioprine as Induction and Maintenance Therapy for Azathioprine-Refractory Crohn's Disease Patients

Thalidomide Combined With Azathioprine as Induction and Maintenance Therapy for Azathioprine-Refractory Crohn's Disease Patients

The combination therapy of thalidomide and azathioprine (AZA) offers an alternative in clinical practice for Crohn's disease (CD) patients experiencing a loss of response to AZA monotherapy. However, little is known about the efficacy and safety of this combination therapy for patients with CD....

Full description

Bibliographic Details
Main Authors: Tong Li, Yun Qiu, Xiaozhi Li, Xiaojun Zhuang, Shanshan Huang, Manying Li, Rui Feng, Baili Chen, Yao He, Zhirong Zeng, Minhu Chen, Shenghong Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Medicine
Subjects:
Crohn disease
azathioprine
thalidomide
loss of response
remission
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2020.557986/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2020.557986/full

Similar Items